Concord Medical Services (NYSE:CCM) Earns Sell Rating from Analysts at StockNews.com

StockNews.com assumed coverage on shares of Concord Medical Services (NYSE:CCM – Free Report) in a research note released on Monday. The firm issued a sell rating on the stock.

Concord Medical Services Stock Performance

Shares of NYSE:CCM opened at $7.18 on Monday. Concord Medical Services has a 1 year low of $3.82 and a 1 year high of $26.70. The company has a debt-to-equity ratio of 1.14, a quick ratio of 0.30 and a current ratio of 0.32. The stock’s 50-day moving average is $6.69 and its 200 day moving average is $6.90.

Concord Medical Services Company Profile

(Get Free Report)

Concord Medical Services Holdings Limited, through its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People's Republic of China. It operates in two segments, Network and Hospital. The company's services include linear accelerators and external beam radiotherapy, proton therapy system, gamma knife radiosurgery, and diagnostic imaging services.

Recommended Stories

• Five stocks we like better than Concord Medical Services
• How Can Investors Benefit From After-Hours Trading
• 3 Momentum Trades for October With Ample Upside Ahead
• Buy P&G Now, Before It Sets A New All-Time High
• Roblox Dips on Short Report—Here’s Why It Could Bounce Back Fast
• 5 discounted opportunities for dividend growth investors
• 2 Reasons to Jump on Apple Stock Now and 1 Reason to Think Twice